Posted by Michael Wonder on 21 Apr 2022
Bridge to Life receives breakthrough device designation from the FDA
21 April 2022 - Bridge to Life advances their perfusion system development with the breakthrough device designation for the LifeCradle Heart Preservation Transport System.
Bridge to Life announced breakthrough device designation authorisation by the U.S. FDA for its LifeCradle Heart Preservation Transport System.
